Technetium (99mTc) microspheres

Explore Technetium (99mTc) microspheres, a vital radiopharmaceutical for diagnostic imaging. Learn about its medical uses, dosage, and potential side effec

Technetium (99mTc) microspheres Technetium-99m lung scan Pulmonary embolism diagnosis Radionuclide imaging Tc-99m MAA Ventilation-perfusion scan Nuclear medicine diagnostics Radiopharmaceutical uses
🏷 ATC Code: V09EB01 📂 V09 Diagnostic radiopharmaceuticals; V09E Respiratory system; V09EB Technetium (99mTc) compounds 🕐 Updated: Mar 14, 2026 ✓ Medical Reference

Looking to order Technetium (99mTc) microspheres?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Technetium (99mTc) microspheres?

Technetium (99mTc) microspheres are a vital radiopharmaceutical used in nuclear medicine diagnostics. This agent consists of tiny, biologically inert particles, typically made of human albumin, labeled with the radioactive isotope Technetium-99m (Tc-99m). Technetium-99m is favored for diagnostic imaging due to its ideal properties: a short half-life of approximately six hours, minimizing patient radiation exposure, and the emission of gamma rays suitable for detection by a gamma camera. The microspheres are designed to temporarily lodge in the capillary beds of organs, allowing for detailed imaging of blood flow and perfusion imaging. Their primary application is in evaluating the pulmonary system, especially for diagnosing conditions like pulmonary embolism.

How Does it Work?

The mechanism of action for Technetium (99mTc) microspheres is based on temporary mechanical entrapment. Administered intravenously, the microspheres travel through the bloodstream to the lungs. Due to their specific size (10-100 micrometers), they become temporarily trapped in the pulmonary arterioles and capillaries, proportional to regional blood flow.

The Technetium-99m then emits gamma photons, which are captured by an external gamma camera. This creates detailed images or a "map" of blood distribution within the lungs. Areas of normal blood flow show even radiotracer distribution, while areas with reduced or absent blood flow (e.g., due to a blood clot) appear as "cold spots." This visualization provides critical diagnostic information about regional pulmonary perfusion.

Medical Uses

The primary medical application of Technetium (99mTc) microspheres is in the diagnosis and evaluation of pulmonary embolism (PE). PE occurs when a blood clot blocks an artery in the lungs.

  • Pulmonary Embolism Diagnosis

    The microspheres are a key component of a ventilation-perfusion (V/Q) scan. By comparing perfusion images (blood flow) with ventilation images (air flow), clinicians identify "mismatches" – areas where air enters normally but blood flow is impaired. This pattern is highly indicative of PE. The V/Q scan is a non-invasive, sensitive method for detecting PE, especially when CT pulmonary angiography (CTPA) is contraindicated.

  • Quantitative Lung Perfusion Studies

    Technetium (99mTc) microspheres can also assess regional lung perfusion in conditions like chronic obstructive pulmonary disease (COPD), for pre-operative evaluation before lung surgery, and in some cases of congenital heart disease affecting pulmonary blood flow.

Dosage

The dosage of Technetium (99mTc) microspheres is meticulously determined by a nuclear medicine physician, considering the patient's age, weight, the specific procedure, and imaging equipment. The goal is to obtain high-quality diagnostic images with the lowest possible radiation exposure (ALARA principle).

For an adult undergoing a standard ventilation-perfusion (V/Q) scan for pulmonary embolism, the typical intravenous dose ranges from 75 to 150 MBq (MegaBecquerels). Pediatric doses are adjusted based on body weight. The microspheres are suspended in a sterile solution and injected slowly intravenously. After injection, a brief wait allows for optimal distribution before imaging. Administration is always performed by trained healthcare professionals in a specialized nuclear medicine department.

Side Effects

Technetium (99mTc) microspheres are generally well-tolerated, with significant side effects being rare. The small number of microspheres administered (a tiny fraction of lung capillaries) means temporary capillary blockade is clinically insignificant.

Potential side effects, though infrequent, include:

  • Allergic Reactions

    Hypersensitivity to albumin or other components is extremely rare but possible.

  • Injection Site Reactions

    Mild pain, redness, or swelling at the injection site, similar to any intravenous injection.

  • Radiation Exposure

    There is a small, controlled amount of radiation exposure, generally considered low and comparable to other diagnostic imaging. The short half-life of Technetium-99m (6 hours) ensures rapid decay and elimination from the body. Patients should report any known allergies.

Drug Interactions

Direct drug interactions with Technetium (99mTc) microspheres are not a major concern, as the microspheres are physically trapped rather than metabolically processed. Interactions primarily relate to conditions or medications that alter pulmonary blood flow, affecting scan distribution patterns.

For instance:

  • Medications affecting pulmonary circulation

    Drugs altering pulmonary vascular tone could theoretically influence microsphere distribution, but this rarely poses a significant issue in routine diagnostics.

  • Other imaging agents

    Recent administration of other radiopharmaceuticals or contrast agents might interfere with perfusion imaging quality due to scatter or background noise.

  • Patient conditions

    Severe pulmonary hypertension or right-to-left shunts can alter typical microsphere distribution, which is crucial for interpretation.

Patients should always provide a complete list of medications to their healthcare provider before any nuclear medicine procedure.

FAQ

  • Q: Is the radiation from Technetium (99mTc) microspheres dangerous?

    A: The radiation dose is very low and considered safe for diagnostic purposes. The short half-life ensures rapid decay and elimination, minimizing long-term exposure. Benefits typically outweigh minimal risks.

  • Q: How long does a scan using Technetium (99mTc) microspheres take?

    A: The actual imaging for the perfusion scan is usually 15-30 minutes. The entire procedure, including preparation and positioning, may take longer, especially if a ventilation-perfusion (V/Q) scan is performed.

  • Q: Do I need to prepare for the scan?

    A: Specific instructions will be provided. Generally, no strict dietary restrictions. Inform your doctor about allergies (especially to albumin), pregnancy, or breastfeeding.

  • Q: What should I expect after the injection?

    A: You'll typically feel only a brief needle prick. Immediate side effects are rare. You'll then be positioned for imaging with the gamma camera.

Products containing Technetium (99mTc) microspheres are available through trusted online pharmacies. You can browse Technetium (99mTc) microspheres-based medications at ShipperVIP or Medicenter.

Summary

Technetium (99mTc) microspheres are a cornerstone in nuclear medicine diagnostics, essential for evaluating pulmonary blood flow. This radiopharmaceutical provides a non-invasive and highly effective method for diagnosing conditions like pulmonary embolism through precise perfusion imaging. Leveraging Technetium-99m's short half-life and gamma-emitting properties, these microspheres enable clinicians to accurately assess regional blood distribution within the lungs. Administered carefully by trained professionals, radiation exposure is minimal. As a vital diagnostic tool, Technetium (99mTc) microspheres continue to play a critical role in guiding patient management and improving outcomes for individuals with suspected pulmonary vascular diseases.